Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

AngioDynamics Inc. (ANGO)

-NasdaqGS

10.68 0.00(0.00%) May 17, 4:00PM EDT

Add to Portfolio
ProfileGet Profile for:
AngioDynamics Inc.
14 Plaza Drive
Latham, NY 12110
United States - Map
Phone: 518-795-1400
Fax: 518-795-1401
Website: http://www.angiodynamics.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:1,400

Business Summary 

AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company operates in two segments, Vascular and Oncology/Surgery. The Vascular segment offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities; angiographic catheters and guidewires used during peripheral vascular interventional procedures; percutaneous transluminal angioplasty dilation balloon catheters; and drainage products that drain abscesses and other fluid pockets. This segment also offers thrombolytic catheters that are used to deliver thrombolytic agents; renal infusion products to deliver drugs directly to the kidneys in order to prevent and treat acute kidney injuries; micro access sets for minimally-invasive procedures; dialysis catheters that provide short and long-term vascular access for dialysis patients; and peripherally inserted central catheters, implantable ports, and central venous catheters. The Oncology/Surgery segment offers radiofrequency ablation products, soft tissue surgical ablation products, microwave ablation products, surgical resection systems, and embolization products for treating benign and malignant tumors. The company markets and sells its products to interventional radiologists, interventional cardiologists, vascular surgeons, and interventional and surgical oncologists directly in the United States; and directly and through distributors internationally. It has a strategic relationship with Microsulis Medical Ltd. The company was founded in 1988 and is headquartered in Latham, New York.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on AngioDynamics Inc.

Corporate Governance 
AngioDynamics Inc.’s ISS Governance QuickScore as of May 1, 2013 is 8. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 9; Compensation: 8.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Joseph M. DeVivo , 46
Chief Exec. Officer, Pres and Director
898.00K0.00
Mr. Stephen J. McGill , 51
Sr. VP and Gen. Mang. of International
357.00K0.00
Mr. Alan F. Panzer , 52
Sr. VP and Gen. Mang. of US Sales
331.00K0.00
Mr. Mark T. Frost , 49
Chief Financial Officer
N/AN/A
Mr. George W. Bourne IV, 53
Chief Technology & Operations Officer and Sr. VP
N/AN/A
Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders